Xiaoyi Yuan

3.4k total citations · 2 hit papers
61 papers, 2.2k citations indexed

About

Xiaoyi Yuan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoyi Yuan has authored 61 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Cancer Research and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoyi Yuan's work include Cancer, Hypoxia, and Metabolism (13 papers), Adenosine and Purinergic Signaling (9 papers) and MicroRNA in disease regulation (8 papers). Xiaoyi Yuan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (13 papers), Adenosine and Purinergic Signaling (9 papers) and MicroRNA in disease regulation (8 papers). Xiaoyi Yuan collaborates with scholars based in United States, China and Germany. Xiaoyi Yuan's co-authors include Holger K. Eltzschig, Wei Ruan, Nathaniel K. Berg, David B. Corry, Farrah Kheradmand, Jessica L. Bowser, Viola Neudecker, Jae W. Lee, Li-zhen Song and Fan Wu and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Xiaoyi Yuan

57 papers receiving 2.2k citations

Hit Papers

Circadian rhythm as a therapeutic target 2021 2026 2022 2024 2021 2023 50 100 150 200 250

Peers

Xiaoyi Yuan
Stilla Frede Germany
Philip Owens United States
Tingting Weng United States
Hong Dang United States
Dylan G. Ryan United Kingdom
Heather L. Wilson United Kingdom
Dachuan Zhang United States
Stilla Frede Germany
Xiaoyi Yuan
Citations per year, relative to Xiaoyi Yuan Xiaoyi Yuan (= 1×) peers Stilla Frede

Countries citing papers authored by Xiaoyi Yuan

Since Specialization
Citations

This map shows the geographic impact of Xiaoyi Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyi Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyi Yuan more than expected).

Fields of papers citing papers by Xiaoyi Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyi Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyi Yuan. The network helps show where Xiaoyi Yuan may publish in the future.

Co-authorship network of co-authors of Xiaoyi Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyi Yuan. A scholar is included among the top collaborators of Xiaoyi Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyi Yuan. Xiaoyi Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Ethan R., Sanming Li, Yanyu Wang, et al.. (2024). Transcriptional Responses of Different Brain Cell Types to Oxygen Decline. Brain Sciences. 14(4). 341–341. 1 indexed citations
2.
Shi, Xinyu, Xiaoyi Yuan, Danya Liu, et al.. (2024). PPM1G‐mediated TBL1X mRNA splicing promotes cell migration in hepatocellular carcinoma. Cancer Science. 116(1). 67–80.
3.
Figarella, Katherine, Ji‐Eun Kim, Wei Ruan, et al.. (2024). Hypoxia-adenosine axis as therapeutic targets for acute respiratory distress syndrome. Frontiers in Immunology. 15. 1328565–1328565. 11 indexed citations
4.
Ruan, Wei, et al.. (2023). The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer. Frontiers in Immunology. 14. 1163585–1163585. 12 indexed citations
5.
Ruan, Wei, Jiwen Li, Yafen Liang, et al.. (2023). Targeting myocardial equilibrative nucleoside transporter ENT1 provides cardioprotection by enhancing myeloid Adora2b signaling. JCI Insight. 8(11). 11 indexed citations
6.
Eltzschig, Holger K., et al.. (2023). Therapeutic targeting of hypoxia inducible factor in acute respiratory distress syndrome. The Journal of Physiology. 602(21). 5745–5756.
7.
Yuan, Xiaoyi, Wei Ruan, Bentley J. Bobrow, Peter Carmeliet, & Holger K. Eltzschig. (2023). Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nature Reviews Drug Discovery. 23(3). 175–200. 95 indexed citations breakdown →
8.
Vohwinkel, Christine U., Nana Burns, Xiaoyi Yuan, et al.. (2022). HIF1A-dependent induction of alveolar epithelial PFKFB3 dampens acute lung injury. JCI Insight. 7(24). 17 indexed citations
9.
Li, Jiwen, Wei Ruan, Xiaoyi Yuan, et al.. (2022). Myeloid hypoxia-inducible factor HIF1A provides cardio-protection during ischemia and reperfusion via induction of netrin-1. Frontiers in Cardiovascular Medicine. 9. 970415–970415. 9 indexed citations
10.
Berg, Nathaniel K., Jiwen Li, Boyun Kim, et al.. (2021). Hypoxia‐inducible factor‐dependent induction of myeloid‐derived netrin‐1 attenuates natural killer cell infiltration during endotoxin‐induced lung injury. The FASEB Journal. 35(4). e21334–e21334. 16 indexed citations
11.
Ju, Cynthia, Meng Wang, Eunyoung Tak, et al.. (2021). Hypoxia-inducible factor–1α–dependent induction of miR122 enhances hepatic ischemia tolerance. Journal of Clinical Investigation. 131(7). 40 indexed citations
12.
Vohwinkel, Christine U., Nana Burns, Hanan Elajaili, et al.. (2021). Targeting alveolar‐specific succinate dehydrogenase A attenuates pulmonary inflammation during acute lung injury. The FASEB Journal. 35(4). e21468–e21468. 27 indexed citations
13.
Li, Jiwen, Catharina Conrad, Tingting Mills, et al.. (2021). PMN-derived netrin-1 attenuates cardiac ischemia-reperfusion injury via myeloid ADORA2B signaling. The Journal of Experimental Medicine. 218(6). 32 indexed citations
14.
Kim, Boyun, et al.. (2021). Characterization of a Murine Model System to Study MicroRNA-147 During Inflammatory Organ Injury. Inflammation. 44(4). 1426–1440. 6 indexed citations
15.
Madison, Matthew C., M J Hong, Xiaoyi Yuan, et al.. (2019). A Novel Animal Model of Emphysema Induced by Anti-Elastin Autoimmunity. The Journal of Immunology. 203(2). 349–359. 6 indexed citations
16.
Yuan, Xiaoyi, Cheng-Yen Chang, Ran You, et al.. (2019). Cigarette smoke–induced reduction of C1q promotes emphysema. JCI Insight. 4(13). 30 indexed citations
17.
Bhavani, Sivasubramanium V., Xiaoyi Yuan, Ran You, et al.. (2015). Loss of Peripheral Tolerance in Emphysema. Phenotypes, Exacerbations, and Disease Progression. Annals of the American Thoracic Society. 12(Supplement_2). S164–S168. 11 indexed citations
18.
Millien, Valentine O., Wen Lu, Garbo Mak, et al.. (2014). Airway Fibrinogenolysis and the Initiation of Allergic Inflammation. Annals of the American Thoracic Society. 11(Supplement_5). S277–S283. 15 indexed citations
19.
Millien, Valentine O., Wen Lu, Joanne Shaw, et al.. (2013). Cleavage of Fibrinogen by Proteinases Elicits Allergic Responses Through Toll-Like Receptor 4. Science. 341(6147). 792–796. 177 indexed citations
20.
Shan, Ming, Xiaoyi Yuan, Li-zhen Song, et al.. (2012). Cigarette Smoke Induction of Osteopontin (SPP1) Mediates T H 17 Inflammation in Human and Experimental Emphysema. Science Translational Medicine. 4(117). 117ra9–117ra9. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026